194 related articles for article (PubMed ID: 10421222)
1. Relationship between serum leptin and the insulin-like growth factor-I system in humans.
Grégoire Nyomba BL; Johnson M; Berard L; Murphy LJ
Metabolism; 1999 Jul; 48(7):840-4. PubMed ID: 10421222
[TBL] [Abstract][Full Text] [Related]
2. Circulating levels of free insulin-like growth factors in obese subjects: the impact of type 2 diabetes.
Frystyk J; Skjaerbaek C; Vestbo E; Fisker S; Orskov H
Diabetes Metab Res Rev; 1999; 15(5):314-22. PubMed ID: 10585616
[TBL] [Abstract][Full Text] [Related]
3. Effect of obesity on total and free insulin-like growth factor (IGF)-1, and their relationship to IGF-binding protein (BP)-1, IGFBP-2, IGFBP-3, insulin, and growth hormone.
Nam SY; Lee EJ; Kim KR; Cha BS; Song YD; Lim SK; Lee HC; Huh KB
Int J Obes Relat Metab Disord; 1997 May; 21(5):355-9. PubMed ID: 9152736
[TBL] [Abstract][Full Text] [Related]
4. Circulating levels of insulin-like growth factor (IGF) binding protein-1 and -3 in aging men: relationships to insulin, glucose, IGF, and dehydroepiandrosterone sulfate levels and anthropometric measures.
Benbassat CA; Maki KC; Unterman TG
J Clin Endocrinol Metab; 1997 May; 82(5):1484-91. PubMed ID: 9141538
[TBL] [Abstract][Full Text] [Related]
5. Serum levels of insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 in healthy centenarians: relationship with plasma leptin and lipid concentrations, insulin action, and cognitive function.
Paolisso G; Ammendola S; Del Buono A; Gambardella A; Riondino M; Tagliamonte MR; Rizzo MR; Carella C; Varricchio M
J Clin Endocrinol Metab; 1997 Jul; 82(7):2204-9. PubMed ID: 9215295
[TBL] [Abstract][Full Text] [Related]
6. Circulating IGF binding protein-1 is inversely associated with leptin in non-obese men and obese postmenopausal women.
Söderberg S; Ahrén B; Eliasson M; Dinesen B; Brismar K; Olsson T
Eur J Endocrinol; 2001 Mar; 144(3):283-90. PubMed ID: 11248749
[TBL] [Abstract][Full Text] [Related]
7. Leptin concentrations in serum from a randomly recruited sample of 50- to 80-year-old men and women: positive association with plasma insulin-like growth factors (IGFs) and IGF-binding protein-3 in lean, but not in obese, individuals.
Seck T; Englaro P; Blum WF; Scheidt-Nave C; Rascher W; Ziegler R; Pfeilschifter J
Eur J Endocrinol; 1998 Jan; 138(1):70-5. PubMed ID: 9461319
[TBL] [Abstract][Full Text] [Related]
8. Serum leptin response to the acute and chronic administration of growth hormone (GH) to elderly subjects with GH deficiency.
Gill MS; Toogood AA; Jones J; Clayton PE; Shalet SM
J Clin Endocrinol Metab; 1999 Apr; 84(4):1288-95. PubMed ID: 10199769
[TBL] [Abstract][Full Text] [Related]
9. Serum levels of insulin-like growth factor system components and relationship to bone metabolism in Type 1 and Type 2 diabetes mellitus patients.
Jehle PM; Jehle DR; Mohan S; Böhm BO
J Endocrinol; 1998 Nov; 159(2):297-306. PubMed ID: 9795371
[TBL] [Abstract][Full Text] [Related]
10. Modulation of circulating IGF-I and IGFBP-3 levels by hormonal regulators of energy homeostasis in obese children.
Woelfle JF; Harz K; Roth C
Exp Clin Endocrinol Diabetes; 2007 Jan; 115(1):17-23. PubMed ID: 17286229
[TBL] [Abstract][Full Text] [Related]
11. Serum insulin-like growth factor (IGF)-I and IGF-binding protein-1 in elderly people: relationships with cardiovascular risk factors, body composition, size at birth, and childhood growth.
Kajantie E; Fall CH; Seppälä M; Koistinen R; Dunkel L; Ylihärsilä H; Osmond C; Andersson S; Barker DJ; Forsén T; Holt RI; Phillips DI; Eriksson J
J Clin Endocrinol Metab; 2003 Mar; 88(3):1059-65. PubMed ID: 12629086
[TBL] [Abstract][Full Text] [Related]
12. Influence of chronic Naltrexone treatment on growth hormone and insulin secretion in obese subjects.
De Marinis L; Mancini A; Valle D; Bianchi A; De Luca AM; Fulghesu AM; Villa P; Mancuso S; Lanzone A
Int J Obes Relat Metab Disord; 1997 Nov; 21(11):1076-81. PubMed ID: 9368834
[TBL] [Abstract][Full Text] [Related]
13. Growth hormone secretion and leptin in morbid obesity before and after biliopancreatic diversion: relationships with insulin and body composition.
De Marinis L; Bianchi A; Mancini A; Gentilella R; Perrelli M; Giampietro A; Porcelli T; Tilaro L; Fusco A; Valle D; Tacchino RM
J Clin Endocrinol Metab; 2004 Jan; 89(1):174-80. PubMed ID: 14715846
[TBL] [Abstract][Full Text] [Related]
14. The metabolic syndrome and insulin-like growth factor I regulation in adolescent obesity.
Attia N; Tamborlane WV; Heptulla R; Maggs D; Grozman A; Sherwin RS; Caprio S
J Clin Endocrinol Metab; 1998 May; 83(5):1467-71. PubMed ID: 9589640
[TBL] [Abstract][Full Text] [Related]
15. Serum levels of insulin-like growth factor (IGF)-I, free IGF-I, IGF binding protein (IGFBP)-1, IGFBP-3 and insulin in obese children.
Park MJ; Kim HS; Kang JH; Kim DH; Chung CY
J Pediatr Endocrinol Metab; 1999; 12(2):139-44. PubMed ID: 10392359
[TBL] [Abstract][Full Text] [Related]
16. Interactions between serum leptin, the insulin-like growth factor-I system, and sex, age, anthropometric and body composition variables in a healthy population randomly selected.
Gómez JM; Maravall FJ; Gómez N; Navarro MA; Casamitjana R; Soler J
Clin Endocrinol (Oxf); 2003 Feb; 58(2):213-9. PubMed ID: 12580938
[TBL] [Abstract][Full Text] [Related]
17. Serum concentrations of insulin, insulin-like growth factor(IGF)-I, IGF binding protein (IGFBP)-1 and -3 and growth hormone binding protein in obese children: fasting IGFBP-1 is suppressed in normoinsulinaemic obese children.
Saitoh H; Kamoda T; Nakahara S; Hirano T; Nakamura N
Clin Endocrinol (Oxf); 1998 Apr; 48(4):487-92. PubMed ID: 9640416
[TBL] [Abstract][Full Text] [Related]
18. The effect of growth hormone on bioactive IGF in overweight/obese women.
Dichtel LE; Bjerre M; Schorr M; Bredella MA; Gerweck AV; Russell BM; Frystyk J; Miller KK
Growth Horm IGF Res; 2018 Jun; 40():20-27. PubMed ID: 29679919
[TBL] [Abstract][Full Text] [Related]
19. Changes in free insulin-like growth factor-1 and leptin concentrations during acute metabolic decompensation in insulin withdrawn patients with type 1 diabetes.
Attia N; Caprio S; Jones TW; Heptulla R; Holcombe J; Silver D; Sherwin RS; Tamborlane WV
J Clin Endocrinol Metab; 1999 Jul; 84(7):2324-8. PubMed ID: 10404797
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic value of the acid-labile subunit in acromegaly: evaluation in comparison with insulin-like growth factor (IGF) I, and IGF-binding protein-1, -2, and -3.
Arosio M; Garrone S; Bruzzi P; Faglia G; Minuto F; Barreca A
J Clin Endocrinol Metab; 2001 Mar; 86(3):1091-8. PubMed ID: 11238491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
